Status:
COMPLETED
Behavioral Effects of Pregabalin and Cannabis
Lead Sponsor:
Joshua A. Lile, Ph.D.
Conditions:
Cannabis-use Disorders
Eligibility:
All Genders
18-50 years
Phase:
EARLY_PHASE1
Brief Summary
Cannabis is the most commonly used illicit drug in the United States, and its use is associated with rates of development of abuse and dependence, treatment admission and relapse that are comparable t...
Eligibility Criteria
Inclusion
- regular cannabis use
- good health other than cannabis use
- willingness to attempt abstinence
- effective form of birth control in female subjects
- available for up to 6 hrs every day for two 2-week test periods with an intervening break of 7-10 days each
- located in close proximity to University of Kentucky
Exclusion
- medical screening outcomes outside normal ranges or deemed clinically insignificant
- medical history that would contraindicate pregabalin administration
Key Trial Info
Start Date :
February 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01511640
Start Date
February 1 2017
End Date
March 15 2020
Last Update
September 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Human Behavioral Pharmacology
Lexington, Kentucky, United States, 40536-0086